United States · Investor

National Cancer Institute (NCI)

Last cheque observed Sep 2026; 73 cheques on record.

Deploying nowInvestment firm

GrantVentureSeedBiotechnologyHealth Care

Deploying now
72%of best year13cheques in 12 months, 73 on record
Since the last cheque55days00hrs00min00sec
Median round$2.1MRounds led0 of 73Sole investor31 roundsMostly inUnited States, 100%
Pitch National Cancer Institute (NCI)

National Cancer Institute (NCI) highlights

  1. 01

    13 cheques in the last 12 months

  2. 02

    Mostly Grant and Venture: 90% of its rounds

  3. 03

    Sole investor in 31 rounds, median $2.0M

What they do

Type
Investment firm (from a list, unverified)
Cheque size
Not stated
Sectors
BiotechnologyHealth Care
Based in
United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first73 appearances

  1. 2026

    11 rounds

  2. Sept
    AiM Medical RoboticsGrant · US$8.1MWith 2 others
  3. Sept
    MALCOVASeed · US$1.2MWith 1 other
  4. Sept
    Intus BioGrant · US$2.7MWith 1 other
  5. Sept
    SenticellVenture · USUndisclosedWith 2 others
  6. May
    Quiver BioscienceGrant · US$9.3MWith 1 other
  7. May
    QT ImagingUS$10MSole investor
  8. Apr
    Transcode TherapeuticsDebt · US$6.0MWith 2 others
  9. Mar
    Sinopia BiosciencesGrant · US$400KWith 1 other
  10. Feb
    Linnaeus TherapeuticsVenture · US$5.0MSole investor
  11. Feb
    Linnaeus TherapeuticsGrant · US$22MSole investor
  12. Jan
    Vivere OncotherapiesSeed · US$10MWith 2 others
  13. 2025

    15 rounds

  14. Dec
    TretheraGrant · US$2.7MWith 2 others
  15. Nov
    Paramita TherapeuticsGrant · US$353KWith 1 other
  16. Oct
    VeramorphVenture · USUndisclosedWith 2 others
  17. Oct
    Transcode TherapeuticsUS$20MWith 2 others
  18. Oct
    RIVANNAGrant · US$3.0MWith 2 others
  19. Oct
    QT ImagingUS · Firms' own news pages$18MWith 2 others
  20. Sept
    Allterum TherapeuticsGrant · US$1.0MWith 1 other
  21. Sept
    NavrogenVenture · USUndisclosedWith 2 others
  22. Jul
    Quiver BioscienceVenture · USUndisclosedSole investor
  23. Jul
    MetasTx LLCGrant · US$400KWith 1 other
  24. Jun
    Lamassu PharmaGrant · US$2.7MWith 1 other
  25. Feb
    Resolute ScienceVenture · USUndisclosedSole investor
  26. Feb
    mPath HealthVenture · USUndisclosedWith 1 other
  27. Feb
    Navega TherapeuticsGrant · US$4.0MWith 1 other
  28. Jan
    ZetaGen TherapeuticsSeries B · US$13MWith 2 others
  29. 2024

    8 rounds

  30. Dec
    Tiga TXGrant · US$36MSole investor
  31. Nov
    Polygon Health AnalyticsGrant · US$296KSole investor
  32. Oct
    PreviseGrant · US$1.8MWith 2 others
  33. Sept
    Palm TherapeuticsGrant · US$250KSole investor
  34. Sept
    Xylyx BioGrant · US$2.5MWith 2 others
  35. Sept
    Ananya HealthGrant · US$2.3MWith 1 other
  36. Aug
    VoximetryGrant · US$2.0MSole investor
  37. May
    Matter BioVenture · USUndisclosedWith 2 others
  38. 2023

    13 rounds

  39. Oct
    Microvascular TherapeuticsGrant · US$4.0MWith 2 others
  40. Oct
    Modifi BioSeed · US$4.3MWith 1 other
  41. Sept
    Saros TherapeuticsGrant · US$2.0MSole investor
  42. Aug
    Current SurgicalVenture · USUndisclosedWith 3 others
  43. Jun
    HelocyteGrant · US$3.2MSole investor
  44. Jun
    HistolixGrant · US$3.2MSole investor

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Who they invest alongside

The investors most often in the same rounds as National Cancer Institute (NCI). A count of rooms they were both in, not a relationship either has claimed.

National Institutes of HealthGovernment11rounds togetherNational Science FoundationGovernment8rounds togetherNational Heart, Lung and Blood InstituteVC firm3rounds togetherY CombinatorAccelerator3rounds togetherBen Franklin Technology PartnersGovernment2rounds togetherBen Franklin Technology Partners of Southeastern PennsylvaniaGovernment2rounds togetherConnecticut InnovationsGovernment2rounds togetherMassChallengeAccelerator2rounds togetherMassVenturesVC firm2rounds togetherMedTech InnovatorAccelerator2rounds togetherNational Institute of Allergy and Infectious DiseasesInvestment firm2rounds togetherRed Cedar VenturesVC firm2rounds together

Recently backed

The latest companies National Cancer Institute (NCI) put money into.

AiM Medical Robotics$8.1M · Sept 2026MALCOVA$1.2M · Sept 2026Intus Bio$2.7M · Sept 2026SenticellSept 2026Quiver Bioscience$9.3M · May 2026QT Imaging$10M · May 2026

Quick answers about National Cancer Institute (NCI)

What does National Cancer Institute (NCI) invest in?

National Cancer Institute (NCI) invests most often at Grant and Venture (90% of the rounds on record), in sectors such as Biotechnology and Health Care.

How active is National Cancer Institute (NCI)?

73 investments on record, 13 of them in the last 12 months. The most recent was in Sept 2026.

What has National Cancer Institute (NCI) invested in recently?

Its most recent investments on record: AiM Medical Robotics (Grant, Sept 2026), MALCOVA (Seed, Sept 2026) and Intus Bio (Grant, Sept 2026).

How big are National Cancer Institute (NCI)'s cheques?

The median round it joins is $2.1M.

Does National Cancer Institute (NCI) lead rounds?

Rarely, if at all: none of its 73 investments on record names it as the lead.

Where does National Cancer Institute (NCI) invest?

Most of the companies it backs are in the United States (100%).

Is National Cancer Institute (NCI) investing now?

Yes: it is actively investing, with 13 investments in the last 12 months.

Who does National Cancer Institute (NCI) invest alongside?

Most often National Institutes of Health (11 rounds together), National Science Foundation (8 rounds together) and National Heart, Lung and Blood Institute (3 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it